Meet And Network With The Key Influencers Shaping The Law, Policy And Proceedings of Paragraph IV Litigation

Each year, leading pharmaceutical patent litigators for brand name and generic drug companies gather at the Paragraph IV Disputes conference to discuss, debate, and analyze the latest trends, judicial rulings and legislative developments affecting Hatch-Waxman litigation.

As the industry prepares to address the fall out of global pharmaceutical patent losses of billions of dollars on the Hatch-Waxman landscape, the time for this conference has never been more relevant.

2020 CO-CHAIRS

Stephanie Donahue

Principal Counsel, Patent Litigation
Sanofi

“The ACI PIV conference is the “must attend” conference for any Hatch-Waxman practitioner. No other conference provides the opportunity to hear from and network with the top in-house representatives and leading law firms representing companies on both sides of the “v.” This conference annually delivers lively discussion and debate with thought leaders on up-to-the-minute trends and hot-button issues in this specialized practice area.”

Pearl T. L. Siew

Senior Vice President and Head, Intellectual Property
Eagle Pharmaceuticals, Inc.

“I’m very excited about ACI PIV 2020. This conference brings together many of the top contributors in Paragraph IV litigation, from in-house and outside counsel to Patent Office, District Court, and Federal Circuit Judges. It’s an excellent opportunity to exchange ideas and shape strategies in larger groups and smaller break-out sessions.”

2020 Key Features

FTC KEYNOTE ADDRESS

Insights on antitrust developments impacting brands and generics

DISTRICT COURT INSIGHTS

Interactive discussions with District Court Judges and Magistrate Judges from D.N.J.; E.D. Pa.; E.D. Tex.

Icon

FOUR NEW BREAKOUT TRACKS

Featuring an In-House Solutions Studio and Litigators War Room

SPECIAL FOCUS SESSIONS ON THE PTAB

APJs Roundtable and advanced discussions on policy, practice, procedure, and the Appointments Clause

Icon

FDA THINK TANK

Initiatives impacting drug access and litigation

Icon

SPOTLIGHT ON DELAWARE

A Conversation with Chief Judge Stark and Chief Magistrate Judge Thynge

Testimonials
Quote Icon

This is the best high-level conference on Paragraph IV disputes. There are no basics here. It’s in-depth level material for experienced practitioners familiar with the nuances of Hatch-Waxman regulatory and litigation practice. The presenters and attendees are all the people who litigate for or work directly for the most active brand and generic companies in the industry. There is no better conference for meeting your counterparts…and opponents.

Senior Vice President, Intellectual Property
Endo Pharmaceuticals Inc.
Quote Icon

…the smaller breakout sessions allow participants to tailor their conference experience to meet their specific needs, and exchange ideas in an intimate and dynamic environment.

Senior VP and Head, Intellectual Property
Eagle Pharmaceuticals
Related Conferences